Background: The cause of cognitive impairment in acutely hospitalized geriatric patients is often unclear. The diagnostic process is challenging but important in order to treat potentially life-threatening etiologies or identify underlying neurodegenerative disease.
Objective: To evaluate the add-on diagnostic value of structural and metabolic neuroimaging in newly manifested cognitive impairment in elderly geriatric inpatients.
Methods: Eighty-one inpatients (55 females, 81.6±5.5 y) without history of cognitive complaints prior to hospitalization were recruited in 10 acute geriatrics clinics. Primary inclusion criterion was a clinical hypothesis of Alzheimer’s disease (AD), cerebrovascular disease (CVD), or mixed AD+CVD etiology (MD), which remained uncertain after standard diagnostic workup. Additional procedures performed after enrollment included detailed neuropsychological testing and structural MRI and FDG-PET of the brain. An interdisciplinary expert team established the most probable etiologic diagnosis (non-neurodegenerative, AD, CVD, or MD) integrating all available data. Automatic multimodal classification based on Random Undersampling Boosting was used for rater-independent assessment of the complementary contribution of the additional diagnostic procedures to the etiologic diagnosis.
Results: Automatic 4-class classification based on all diagnostic routine standard procedures combined reproduced the etiologic expert diagnosis in 31% of the patients (p = 0.100, chance level 25%). Highest accuracy by a single modality was achieved by MRI or FDG-PET (both 45%, p≤0.001). Integration of all modalities resulted in 76% accuracy (p≤0.001).
Conclusion: These results indicate substantial improvement of diagnostic accuracy in uncertain de novo cognitive impairment in acutely hospitalized geriatric patients with the integration of structural MRI and brain FDG-PET into the diagnostic process.
FriedTR, BradleyEH, TowleVR, AlloreH (2002) Understanding the treatment preferences of seriously ill patients. N Engl J Med346, 1061–1066.
2.
Alzheimer’sAssociation (2014) Alzheimer’s Association Report: 2014 Alzheimer’s Disease Facts and figures. Alzheimers Dement10, e47–e92.
3.
(2009) Deutsche Gesellschaft für Neurologie (DGN) und Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde e. V. (DGPPN), AWMF Registernummer, 038–013.
4.
McKhannG, DrachmanD, FolsteinM, KatzmanR, PriceD, StadlanEM (1984) Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology34, 939–944.
5.
KnopmanDS, DeKoskyST, CummingsJL, ChuiH, Corey-BloomJ, RelkinN, SmallGW, MillerB, StevensJC (2001) Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology56, 1143–1153.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCRJr, KawasCH, KlunkWE, KoroshetzWJ, ManlyJJ, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 263–269.
WeiseD, TiepoltS, AwissusC, HoffmannKT, LobsienD, KaiserT, BarthelH, SabriO, GertzHJ (2015) Critical comparison of different biomarkers for Alzheimer’s disease in a clinical setting. J Alzheimers Dis48, 425–432.
10.
BrindleN, HolmesJ (2005) Capacity and coercion: Dilemmas in the discharge of older people with dementia from general hospital settings. Age Ageing34, 16–20.
11.
FrisoniGB, FoxNC, JackCRJr, ScheltensP, ThompsonPM (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol6, 67–77.
12.
SilvermanDH, SmallGW, ChangCY, LuCS, Kung De AburtoMA, ChenW, CzerninJ, RapoportSI, PietriniP, AlexanderGE, SchapiroMB, JagustWJ, HoffmanJM, Welsh-BohmerKA, AlaviA, ClarkCM, SalmonE, de LeonMJ, MielkeR, CummingsJL, KowellAP, GambhirSS, HohCK, PhelpsME (2001) Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA286, 2120–2127.
13.
FolsteinMF, FolsteinSE, McHughPR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res12, 189–198.
14.
KalbeE, KesslerJ, CalabreseP, SmithR, PassmoreAP, BrandM, BullockR (2004) DemTect: A new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry19, 136–143.
15.
MorrisJC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology43, 2412–2414.
16.
ReisbergB, BorensteinJ, SalobSP, FerrisSH, FranssenE, GeorgotasA (1987) Behoral symptoms in Alzheimer’s disease: Phenomenology and treatment. J Clin Psychiatry48 Suppl, 9–15avi.
17.
LesherEL, BerryhillJS (1994) Validation of the Geriatric Depression Scale–Short Form among inpatients. J Clin Psychol50, 256–260.
18.
MonschAU, KressigRW (2010) Specific care program for the older adults: Memory Clinics. Eur Geriatr Med1, 128–131.
MontgomerySA, AsbergM (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry134, 382–389.
21.
JormAF (1994) A short-form of the Informant Questionnaire on Cognitive Decline in the Elderly (Iqcode) - development and cross-validation. Psychol Med24, 145–153.
22.
VarroneA, AsenbaumS, Vander BorghtT, BooijJ, NobiliF, NagrenK, DarcourtJ, KapucuOL, TatschK, BartensteinP, Van LaereK, European Association of Nuclear Medicine Neuroimaging, Committee
(2009) EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging36, 2103–2110.
23.
LangeC, SuppaP, FringsL, BrennerW, SpiesL, BuchertR (2015) Optimization of statistical single subject analysis of brain FDG PET for the prognosis of mild cognitive impairment-to-Alzheimer’s disease conversion. J Alzheimers Dis49, 945–959.
24.
AnderssonJL, VagnhammarBE, SchneiderH (1995) Accurate attenuation correction despite movement during PET imaging. J Nucl Med36, 670–678.
25.
RomanGC, TatemichiTK, ErkinjunttiT, CummingsJL, MasdeuJC, GarciaJA, AmaducciL, OrgogozoJM, BrunA, HofmanA (1993) Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology43, 250–260.
26.
BrenowitzWD, MonsellSE, SchmittFA, KukullWA, NelsonPT (2014) Hippocampal sclerosis of aging is a key Alzheimer’s disease mimic: Clinical-pathologic correlations and comparisons with both Alzheimer’s disease and non-tauopathic frontotemporal lobar degeneration. J Alzheimers Dis39, 691–702.
27.
NelsonPT, SmithCD, AbnerEL, WilfredBJ, WangWX, NeltnerJH, BakerM, FardoDW, KryscioRJ, ScheffSW, JichaGA, JellingerKA, Van EldikLJ, SchmittFA (2013) Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol126, 161–177.
28.
HallerS, LovbladK-O, GiannakopoulosP, Van De VilleD (2014) Multivariate pattern recognition for diagnosis and prognosis in clinical neuroimaging: State of the art, current challenges and future trends. Brain Topogr27, 329–337.
29.
SeiffertC, KhoshgoftaarTM, Van HulseJ, NapolitanoA (2010) RUSBoost: A hybrid approach to alleviating class imbalance. IEEE Trans Syst Man Cybern A Syst Hum40, 185–197.
30.
BishopCM (2007) Pattern Recognition and Machine Learning, Springer.
31.
SuppaP, AnkerU, SpiesL, BoppI, Ruegger-FreyB, KlaghoferR, GockeC, HampelH, BeckS, BuchertR (2015) Fully automated atlas-based hippocampal volumetry for detection of Alzheimer’s disease in a memory clinic setting. J Alzheimers Dis44, 183–193.
32.
SuppaP, HampelH, SpiesL, FiebachJB, DuboisB, BuchertR (2015) Fully automated atlas-based hippocampus volumetry for clinical routine: Validation in subjects with mild cognitive impairment from the ADNI Cohort. J Alzheimers Dis46, 199–209.
33.
RitterK, SchumacherJ, WeygandtM, BuchertR, AllefeldC, HaynesJD (2015) Multimodal prediction of conversion to Alzheimer’s disease based on incomplete biomarkers. Alzheimers Dement (Amst)1, 206–215.
34.
BühlerE, KrenR, StolzK (2012) Betreuungsrecht und Patientenverfügungen: Praktische Informationen für Ärzte und Interessierte, Springer Medizin Verlag GmbH.
35.
GaudreauJD, GagnonP, HarelF, TremblayA, RoyMA (2005) Fast, systematic, and continuous delirium assessment in hospitalized patients: The nursing delirium screening scale. J Pain Symptom Manage29, 368–375.
36.
TrzepaczPT, MulsantBH, DewMA, PasternakR, SweetRA, ZubenkoGS (1998) Is delirium different when it occurs in dementia? A study using the delirium rating scale. J Neuropsychiatry Clin Neurosci10, 199–204.
37.
MatthewsFE, ArthurA, BarnesLE, BondJ, JaggerC, RobinsonL, BrayneC, Medical Research Council Cognitive F, AgeingC (2013) A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: Results of the Cognitive Function and Ageing Study I and II. Lancet382, 1405–1412.
38.
SampsonEL, BlanchardMR, JonesL, TookmanA, KingM (2009) Dementia in the acute hospital: Prospective cohort study of prevalence and mortality. Br J Psychiatry195, 61–66.
39.
MathewsSB, ArnoldSE, EppersonCN (2014) Hospitalization and cognitive decline: Can the nature of the relationship be deciphered?Am J Geriatr Psychiatry22, 465–480.
40.
ShenkinSD, RussTC, RyanTM, MacLullichAM (2014) Screening for dementia and other causes of cognitive impairment in general hospital in-patients. Age Ageing43, 166–168.
41.
WallinA, NordlundA, JonssonM, BlennowK, ZetterbergH, OhrfeltA, StalhammarJ, EckerstromM, CarlssonM, OlssonE, GothlinM, SvenssonJ, RolstadS, EckerstromC, BjerkeM (2016) Alzheimer’s disease-subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies. J Cereb Blood Flow Metab36, 95–113.
42.
ButtonKS, IoannidisJP, MokryszC, NosekBA, FlintJ, RobinsonES, MunafoMR (2013) Power failure: Why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci14, 365–376.
43.
TsoumakasG, KatakisI (2007) Multi-label classification: An overview. Int J Data Warehousing Min2007, 1–13.
44.
DormannCF, ElithJ, BacherS, BuchmannC, CarlG, CarreG, MarquezJRG, GruberB, LafourcadeB, LeitaoPJ, MunkemullerT, McCleanC, OsbornePE, ReinekingB, SchroderB, SkidmoreAK, ZurellD, LautenbachS (2013) Collinearity: A review of methods to deal with it and a simulation study evaluating their performance. Ecography36, 27–46.
45.
MayrA, BinderH, GefellerO, SchmidM (2014) The evolution of boosting algorithms from machine learning to statistical modelling. Methods Inf Med53, 419–427.
46.
GuyonI, ElisseeffA (2003) An introduction to variable and feature selection. J Mach Learn Res3, 1157–1182.
47.
ScheltensP, LeysD, BarkhofF, HugloD, WeinsteinHC, VermerschP, KuiperM, SteinlingM, WoltersEC, ValkJ (1992) Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: Diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry55, 967–972.
